The monoclonal antibody market is expected to reach $524.68 billion by 2030. This highlights the growing demand for monoclonal antibodies in biomedical research, diagnostics, and therapeutic development. Monoclonal antibodies (mAbs) have revolutionized medicine by providing…
Read More
Uncategorized
Single Domain Antibodies
In this blog, ProSci will take you through the advantages of single domain antibodies—also known as Nanobodies™, VHH antibodies, and camelid antibodies—and the process ProSci uses to develop high-performing antibodies. Single Domain Antibodies (sdAbs) from…
Read More
